North Carolina has a long commitment to growing our state’s life science industry and that is indicated in reports by PhRMA highlighting North Carolina as a leader in "in Biotechnology Innovation and Education Amid Growing Global Competition."
Life Science programs received support from the North Carolina General Assembly. Click here for more information.
Panelists had a lot of advice for NCBIO members seeking approval from the FDA. The session was led by Daniel Schultz, M.D., F.A.C.S., Principal, Medical Devices & Combination Products, Greenleaf Health and former Director of the Center for Devices and Radiological Health, Food and Drug Administration. Speakers joining the discussion included: Patrick Daly, President and Chief Executive Officer, Cohera Medical; Tammy Carrea, Vice President of Quality & Regulatory for Baebies; and Tim Willis, Chief Executive Officer and Founder, MED1 Ventures. Thanks to former NCBIO Board Chairman Peyton Anderson, CEO of Affinergy, for providing opening and closing comments and to PwC, Technosoft Innovations, and Wyrick Robbins for sponsoring the Forum.
The new Legislative Joint Life Science Caucus is quickly learning about the industry in North Carolina. At a meeting May 3rd, Kristen Parde of PhRMA discussed how medicines benefit patients, the health care system and the economy. On May 17th, the Caucus received a briefing on the impact of clinical research organizations (CROS) in North Carolina. Rachael Fones and Patrick Jordan of QuintilesIMS discussed the clinical trial process for new drugs and the economic impact of the industry in the State. At the May 31st meeting, the Caucus heard about university collaborations from Dr. James Ryan, Dean of the Joint School of Nanoscience and Nanoengineering School at NC A&T University and UNC-Greensboro, and Dr. Faye Calhoun and Dr. Jonanthan Sexton from BRITE at NC Central University.
Legislators and NCBIO members talked about the future of the life science industry in North Carolina at the 2017 Annual Legislative Reception on April 5th. Thanks to AbbVie, Amgen, Astellas, Bayer, Biogen, Johnson & Johnson, Lilly, Novozymes, PhRMA, and Syngenta for helping make this event possible.
NCBIO was a co-sponsor with the UNC School of Pharmacy and NCCU BRITE for a luncheon hosting former FDA Commissioner Robert Califf. NCBIO Biotech Manufacturers Forum Manager John Wagner and Dr. Califf talk prior to the luncheon.
Companies can use a variety of funding options for early seed and start-up stages according to panelists at the NCBIO Luncheon and Forum, February 7th. NCBIO members heard different perspectives from representatives who discussed venture funding, grant and loan programs, non-dilutive funding, pharmaceutical partnering and more.